Cargando…
Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
BACKGROUND: Vulnerable populations, such as hemodialysis (HD) patients and kidney transplant (RTx) recipients, have priority for anti-COVID-19 vaccination, because of their impaired immune status. Here, we investigated the immune response after vaccination with BNT162b2 (two doses plus booster) in H...
Autores principales: | De Cagna, Maria Rosaria, Colucci, Vincenza, Di Maggio, Arcangelo, Notaristefano, Norma, Cianciotta, Francesca, Danza, Katia, Salvatore, Francesca, Santoniccolo, Anna, Lanzillotta, Salvatore Giovanni, Perniola, Maria Antonietta, Marangi, Anna Lisa, Morrone, Luigi Francesco Pio, Tampoia, Marilina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933795/ https://www.ncbi.nlm.nih.gov/pubmed/36795176 http://dx.doi.org/10.1007/s10157-023-02317-1 |
Ejemplares similares
-
Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART
por: Gianserra, Laura, et al.
Publicado: (2022) -
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021) -
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
por: Piano Mortari, Eva, et al.
Publicado: (2023) -
Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
por: Graceffa, Dario, et al.
Publicado: (2022) -
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
por: Venerito, Vincenzo, et al.
Publicado: (2022)